Columbia SOM
The Tabas Laboratory
PublicationsLab MembersContact UsSelected Laboratory Protocolsbriefs

Technology Briefs

  • Therapeutic targets for preventing non-alcoholic fatty liver disease

  • Uncleavable Mertk knock-in mouse for studying cardiovascular and neuroinflammatory disease

  • Diabetes drug as a candidate for treatment of obesity and other metabolic diseases

  • Treatment of obesity and diabetes through the inhibition of MAPKAPK2 and MAPKAPK3

  • Nanoparticles for targeted delivery of anti-inflammatory agents


    Copyright © 2018 Ira Tabas, MD, PhD. All Rights Reserved.